View the article online at http://citywire.co.uk/wealth-manager/article/a747672
FTSE falls as Russian troops move near Ukraine
A chill swept through stock markets this afternoon after Russia started military drills near the Ukranian border and its defence minister denounced Nato exercises in eastern Europe.
According to Reuters, defence minister Sergei Shoigu was quoted by Russia's Interfax news agency as saying: 'If this military machine is not stopped, it will lead to greater numbers of dead and wounded. Planned exercises by Nato forces in Poland and the Baltic countries do not foster normalisation of the situation surrounding Ukraine, either,' adding, 'We are forced to react to such a development of the situation.'
Shoigu's comments follow attempts by the new government in Kiev to seize back control of areas in eastern Ukraine from pro-Russia separatists this week with five rebels in Slovyansk killed today.
The FTSE 100 shed its earlier six-week high (see below) to trade nine points up on the day at 6,684. AstraZeneca (AZN), which had spiked higher on hopes for its new cancer drugs, lost half its gains to trade 3% up at £41.66.
Fears of the escalating tensions over Ukraine dampened the cheer over Apple's better than expected first quarter results and a $13.3 billion acquisition of Biomet by medical deveice maker Zimmer Holdings, although it did nudge Smith & Nephew (SN) to top of the FTSE leader board in London, up 3.3% at 909p.
The S&P 500 opened up just two points higher while the and the Dow Jones industrial average dipped nine points to 16,492. This was despite more encouraging economic data. Orders for long-lasting US manufactured goods rose 2.6%, ahead of forecasts of 2%, strengthening hopes that the US economic recovery is gathering speed after the winter freeze.
European markets gave up their gains too with the FTSEurofirst 300 flat at 1,388. On another day share prices could have risen in response to figures showing a decline in the amount of spare cash in the eurozone banking system. With liquidity at a two-and-a-half year low adds pressure on the European Central Bank to deliver more stimulus.
Gold gained $3.80 to $1,288 an ounce.
FTSE hits six-week high as Astra continues surge
11.12: The FTSE 100 has hit a six-week high with AstraZeneca (AZN.L) leading the running as a 17% drop in core earnings per share failed to dint enthusiasm for the pharmaceutical giant.
The FTSE added 42 points, or 0.6%, to reach 6,717, led by AstraZeneca, which jumped 244.5p, or 6%, to reach £42.85. Astra has announced first quarter results below market forecasts, but reported that four major experimental medicines, including two cancer drugs, were set for late-stage clinical testing, news that could revive its fortunes.
News sponsored by:
As the UK coalition government strives to rebalance the national economy, so called 'reshoring' looks set to play an increasingly important role in economic recovery.
Today's top headlines
With talk on interest rates on the horizon, our latest roundtable debate covers income investing against a changing backdrop
More about this:
Look up the shares
- AstraZeneca PLC (AZN.L)
- Anglo American PLC (AAL.L)
- Rio Tinto PLC (RIO.L)
- Antofagasta PLC (ANTO.L)
- Unilever PLC (ULVR.L)
- Associated British Foods PLC (ABF.L)